Filing Flows › Firefly Neuroscience (AIFF) › Q1 2026 › vs Q4 2025
Firefly Neuroscience (AIFF) Q1 2026 vs Q4 2025 (quarter over quarter)
Firefly Neuroscience's revenue rose $73K (+18%) from $412K in Q4 2025 to $485K in Q1 2026.
Firefly Neuroscience, Q1 2026: revenue $485K (11× year over year), operating margin -414.4%, net loss $2.0M, operating cash flow −$1.9M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $485K | $412K | $73K | +18% |
| Other income, net | $6K | $22K | −$16K | -73% |
| Net loss | $2.0M | $2.5M | −$476K | -19% |
| Costs & expenses | $2.5M | $2.9M | −$419K | -14% |
| Operating costs | $2.5M | $2.9M | −$418K | -14% |
| Cost of revenue | $264K | $230K | $34K | +15% |
| Research & development | $424K | $456K | −$32K | -7% |
| Sales & marketing | $141K | $128K | $13K | +10% |
| General & admin | $1.7M | $2.0M | −$334K | -17% |
| Operating cash sources | $2.4M | $2.1M | $349K | +17% |
| Depreciation & amortization | $45K | $52K | −$7K | -13% |
| Share-based compensation | $423K | $210K | $213K | +101% |
| Cash used in operations | $1.9M | $1.8M | $143K | +8% |
| Net loss absorbed | $2.0M | $2.5M | −$476K | -19% |
| Working capital & other | $412K | −$413K | $825K | — |
Questions
How much did Firefly Neuroscience's revenue grow quarter over quarter in Q1 2026?
Firefly Neuroscience's revenue rose $73K (+18%) from $412K in Q4 2025 to $485K in Q1 2026.